111 related articles for article (PubMed ID: 25691728)
1. 2013 viral clearance symposia - session 5. Conference summary: key discussion and outcomes, pending questions, and proposed experiments.
Blümel J; Roush D
PDA J Pharm Sci Technol; 2015; 69(1):206-10. PubMed ID: 25691728
[No Abstract] [Full Text] [Related]
2. Proceedings of the 2013 Viral Clearance Symposium (Princeton, NJ).
Roush D; Brorson K; Levy R
PDA J Pharm Sci Technol; 2015; 69(1):140-1. PubMed ID: 25691721
[No Abstract] [Full Text] [Related]
3. Viral clearance using traditional, well-understood unit operations: session 1.2. Anion exchange chromatography; and session 1.3. Protein a chromatography.
Roush D
PDA J Pharm Sci Technol; 2015; 69(1):154-62. PubMed ID: 25691723
[No Abstract] [Full Text] [Related]
4. Session 4: overall integrated viral clearance and adventitious agents strategy.
Blümel J; Tounekti O
PDA J Pharm Sci Technol; 2015; 69(1):195-205. PubMed ID: 25691727
[No Abstract] [Full Text] [Related]
5. Session 2/3: integrated viral clearance strategy and case studies.
Willkommen H
PDA J Pharm Sci Technol; 2015; 69(1):183-94. PubMed ID: 25691726
[No Abstract] [Full Text] [Related]
6. Session 1.5: other viral clearance and inactivation approaches (multimodal chromatography, membrane chromatography, chemical precipitation).
Hubbard B
PDA J Pharm Sci Technol; 2015; 69(1):173-82. PubMed ID: 25691725
[No Abstract] [Full Text] [Related]
7. Viral clearance of traditional unit operations: virus-retentive filtration.
Chen Q; Chen D
PDA J Pharm Sci Technol; 2015; 69(1):142-53. PubMed ID: 25691722
[No Abstract] [Full Text] [Related]
8. Advancing Product Quality: a Summary of the Second FDA/PQRI Conference.
Yu LX; Akseli I; Allen B; Amidon G; Bizjak TG; Boam A; Caulk M; Doleski D; Famulare J; Fisher AC; Furness S; Hasselbalch B; Havel H; Hoag SW; Iser R; Johnson BD; Ju R; Katz P; Lacana E; Lee SL; Lostritto R; McNally G; Mehta M; Mohan G; Nasr M; Nosal R; Oates M; O'Connor T; Polli J; Raju GK; Ramanadham M; Randazzo G; Rosencrance S; Schwendeman A; Selen A; Seo P; Shah V; Sood R; Thien MP; Tong T; Trout BL; Tyner K; Vaithiyalingam S; VanTrieste M; Walsh F; Wesdyk R; Woodcock J; Wu G; Wu L; Yu L; Zezza D
AAPS J; 2016 Mar; 18(2):528-43. PubMed ID: 26860627
[No Abstract] [Full Text] [Related]
9. Efficient medicinal chemistry.
Kyle DJ
Comb Chem High Throughput Screen; 2006 Feb; 9(2):77. PubMed ID: 16475964
[No Abstract] [Full Text] [Related]
10. The first Neurocritical Care Research Conference: a great starting point.
Suarez JI; LeRoux PD
Neurocrit Care; 2012 Feb; 16(1):4-5. PubMed ID: 21786044
[No Abstract] [Full Text] [Related]
11. Michael Hanson.
Hanson M
Nat Rev Drug Discov; 2016 Feb; 15(2):80. PubMed ID: 26837587
[No Abstract] [Full Text] [Related]
12. Psychopharmacology news.
Silva RR
J Child Adolesc Psychopharmacol; 2008 Jun; 18(3):291. PubMed ID: 18582184
[No Abstract] [Full Text] [Related]
13. Trends in Drug Discovery over Five Decades - The European Federation for Medicinal Chemistry International Symposium on Medicinal Chemistry (EFMC-ISMC).
Differding E
ChemMedChem; 2020 Dec; 15(24):2352-2358. PubMed ID: 33241869
[TBL] [Abstract][Full Text] [Related]
14. Structure-based antivirals for emerging and neglected RNA viruses: an emerging field for medicinal chemistry in academia.
Hilgenfeld R
Future Med Chem; 2010 Jul; 2(7):1061-7. PubMed ID: 21426155
[TBL] [Abstract][Full Text] [Related]
15. Proceedings of the 2019 Viral Clearance Symposium, Session 8. Conference Summary: Key Discussion and Outcomes, Pending Questions, and Proposed Experiments and Actions.
Bolton G
PDA J Pharm Sci Technol; 2022; 76(4):362-367. PubMed ID: 34911826
[TBL] [Abstract][Full Text] [Related]
16. Third conference on antiviral substances.
Ann N Y Acad Sci; 1977 Mar; 284():1-720. PubMed ID: 30368
[No Abstract] [Full Text] [Related]
17. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery.
Nair V; Shu Q
Antivir Chem Chemother; 2007; 18(5):245-58. PubMed ID: 18046958
[TBL] [Abstract][Full Text] [Related]
18. Session 5: Conference Summary: Key Discussion and Outcomes, Pending Questions, and Proposed Experiments.
Bolton G; Blümel J
PDA J Pharm Sci Technol; 2016 Sep; 70(5):477-481. PubMed ID: 27516482
[No Abstract] [Full Text] [Related]
19. Chemical biology: contribution to molecular therapeutic innovation--a new role for chemistry? Report from the thematic symposium organized by the SCT (French Medicinal Chemistry Society), November 26th, 2013.
Schmidt F; George P; Sapi J
ACS Chem Biol; 2014 Apr; 9(4):849-52. PubMed ID: 24742389
[No Abstract] [Full Text] [Related]
20. Accelerating Drug Development: Antiviral Therapies for Emerging Viruses as a Model.
Everts M; Cihlar T; Bostwick JR; Whitley RJ
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():155-169. PubMed ID: 27483339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
